RETA
Reata Pharmaceuticals Inc - Ordinary Shares - Class A

2,846
Mkt Cap
$6.57B
Volume
119,893.00
52W High
$172.46
52W Low
$21.83
PE Ratio
-57.67
RETA Fundamentals
Price
$172.37
Prev Close
$172.32
Open
$172.39
50D MA
$163.46
Beta
1.11
Avg. Volume
820,529.65
EPS (Annual)
-$2.99
P/B
74.73
EV/EBITDA
-12.33
Loading...
Loading...
Latest Earnings Results: Q3 '23
Reported: May 27

Estimated EPS

-$2.23

Reported EPS

---

Surprise

---

Estimated Rev

$25.4M

Reported Rev

---

Surprise

---

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q4 '23
-$1.52
--
--
N/A
Q3 '23
-$2.23
--
--
N/A
Q2 '23
-$2.76
--
--
N/A
Q1 '23
-$2.39
-$3.14
-31.21%
MISSED

Latest RETA News

View

Advertisement|Remove ads.

Advertisement|Remove ads.